UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054980
Receipt number R000062797
Scientific Title Hemostasis by Endoscopy based on Appropriate Timing for UPper gi bleeding study
Date of disclosure of the study information 2024/07/19
Last modified on 2024/08/20 14:10:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hemostasis by Endoscopy based on Appropriate Timing for UPper gi bleeding study

Acronym

HEAT UP study

Scientific Title

Hemostasis by Endoscopy based on Appropriate Timing for UPper gi bleeding study

Scientific Title:Acronym

HEAT UP study

Region

Japan


Condition

Condition

Upper gastrointestinal bleeding

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to verify that patients with suspected upper gastrointestinal bleeding who are likely to require endoscopic procedures have a significantly better prognosis in the group that receives a waitlist endoscopy (within 6-24 hours) compared to the group that receives an emergency endoscopy (within 6 hours).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence of further bleeding (bleeding that cannot be stopped by endoscopy or rebleeding once hemostasis is confirmed) within 30 days

Key secondary outcomes

Further bleeding (within 7 and 30 days of allocation)
Bleeding not stopped by initial endoscopy
Rate of initial endoscopic procedures
Rebleeding rate (within 7 and 30 days of allocation)
Transfusion rate, transfusion units (within 30 days of allocation)
Hemostatic angiography rate (within 30 days of allocation)
Hemostatic surgery rate (within 30 days of allocation)
All-cause mortality (within 30 days of allocation)
Hospitalization days
Number of days spent in intensive care units (ICUs, HCUs, critical care centers, etc.)
Cost
Adverse events (from allocation to endoscopy and within 30 days)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Waiting group for endoscopy 6-24 hours from the time of consultation with the gastroenterologist

Interventions/Control_2

Emergency group for endoscopy within 6 hours from the time of consultation with the gastroenterologist

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with suspected upper gastrointestinal bleeding
Patients with a HARBINGER of 2 or 3

Key exclusion criteria

(i) Persistent fresh hematemesis or hematochezia after consultation with a gastroenterologist
(ii) Patients with blood pressure less than 90 mmHg at study entry (patients with blood pressure less than 90 mmHg before entry but recovered by transfusion etc. are not excluded)
(iii) Unable to obtain the patient's consent (e.g., impaired consciousness or dementia)
(iv) Medically-induced bleeding (e.g., after ESD, EMR, or biopsy)
(v) Pregnant women
(vi) Patients with terminal cancer whose prognosis is expected to be within 3 months (regardless of carcinoma)
(vii) Patients who are judged to be unsuitable by the treating physician

Target sample size

1070


Research contact person

Name of lead principal investigator

1st name Motohiko
Middle name
Last name Kato

Organization

Keio University Hospital

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0353633790

Email

motohikokato@keio.jp


Public contact

Name of contact person

1st name Masayasu
Middle name
Last name Horibe

Organization

Keio University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0353633790

Homepage URL


Email

masayasu.horibe@gmail.com


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name

Masayasu Horibe


Funding Source

Organization

Takeda Science Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

0333531211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 07 Month 09 Day

Date of IRB

2024 Year 07 Month 19 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 07 Month 16 Day

Last modified on

2024 Year 08 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000062797


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name